FDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing

Five Star Equities Provides Stock Research on ACADIA Pharmaceuticals and BioCryst Pharmaceuticals

Continue Reading

Refiners Slump as Renewable Fuel Credits Rise to Over US$1.00/Gal in 2013

RDInvesting Provides Stock Research on Marathon Petroleum and Northern Tier Energy

Continue Reading

New Programs Designed to Speed up Approval Process a Key Factor in Biotech Industry-s Growth in 2012

Five Star Equities Provides Stock Research on NPS Pharmaceuticals and Sinovac Biotech

Continue Reading

Coal Imports from China and the United Kingdom on the Rise in 2013

RDInvesting Provides Stock Research on Alpha Natural Resources and Peabody Energy

Continue Reading

Foreign Demand for Coal Grows on Increased Imports From China and the United Kingdom

RDInvesting Provides Stock Research on Arch Coal and James River Coal Company

Continue Reading

Chinese Equities- Struggles Continue as China-s Cabinet Announces Measures to Curb Rising Home Prices

Five Star Equities Provides Stock Research on E Commerce China Dangdang and Youku Tudou

Continue Reading

Refiners Battle Sharp Increase in Renewable Fuel Credits in 2013

RDInvesting Provides Stock Research on CVR Energy and Phillips 66

Continue Reading

Retail Stocks Spike as February Retail Sales Posts Biggest Gain in Five Months

Five Star Equities Provides Stock Research on Abercrombie & Fitch and NIKE

Continue Reading

Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech-s Industry Success

Five Star Equities Provides Stock Research on Array Biopharma and PDL BioPharma

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

RDInvesting Provides Stocks Research on Acura Pharmaceuticals and Sunesis Pharmaceuticals

Continue Reading